Semin Thromb Hemost. 2002 Aug;28 Suppl 3:33-9.

Mapping out the future in venous thromboembolism and acute coronary syndromes.

Source

Division of Cardiovascular Diseases, Section of Vascular Diseases, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA. heit.john@mayo.edu

Abstract

Identification of risk factors for incident venous thromboembolism and predictors of recurrent venous thromboembolism and appropriate antithrombotic prophylaxis and therapy are vital to improve survival after pulmonary embolism and prevent complications such as venous stasis syndrome after deep-vein thrombosis. Risk stratification is increasingly important; future prophylaxis and treatment strategies should be targeted to the patients who will derive the greatest benefit. For established antithrombotic agents, the most appropriate dose, dosing schedule, and duration of prophylaxis and therapy are being refined. In addition, new antithrombotic agents such as the oral direct thrombin inhibitors are being identified and developed. The management of acute arterial thrombosis (for example, acute coronary syndromes) is an important and relatively new indication for antithrombotic agents such as the low-molecular-weight heparins and the platelet glycoprotein IIb/IIIa antagonists.

PMID:: 12232821; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Prophylaxis against venous thromboembolism in orthopedic surgery. [Chin J Traumatol. 2006]
Review Prophylaxis against venous thromboembolism in orthopedic surgery.
Liu LT, Ma BT. Chin J Traumatol. 2006 Aug; 9(4):249-56.
Review [Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials)]. [Medicina (Kaunas). 2003]
Review [Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials)].
Valiukiene L, Naudziūnas A, Unikauskas A. Medicina (Kaunas). 2003; 39(4):352-8.
Review Assessing, preventing, and treating venous thromboembolism: evidence-based approaches. [Am J Health Syst Pharm. 2007]
Review Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.
Nutescu EA. Am J Health Syst Pharm. 2007 Jun 1; 64(11 Suppl 7):S5-13.
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. [Haematologica. 2008]
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V, Za T, Rossi E, Vannucchi AM, Ruggeri M, Elli E, Micò C, Tieghi A, Cacciola RR, Santoro C, et al. Haematologica. 2008 Mar; 93(3):372-80. Epub 2008 Feb 11.
Review New strategies for the treatment of acute venous thromboembolism. [Semin Thromb Hemost. 2006]
Review New strategies for the treatment of acute venous thromboembolism.
Prandoni P, Lensing AW, Pesavento R. Semin Thromb Hemost. 2006 Nov; 32(8):787-92.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Mapping out the future in venous thromboembolism and acute coronary syndromes.
Mapping out the future in venous thromboembolism and acute coronary syndromes.
Semin Thromb Hemost. 2002 Aug ;28 Suppl 3:33-9.

PubMed
The C-terminal activation domain of the STAT-1 transcription factor is necessary...
The C-terminal activation domain of the STAT-1 transcription factor is necessary and sufficient for stress-induced apoptosis.
Cell Death Differ. 2002 Oct ;9(10):1140-6.

PubMed
Isolation of AmphiCASP-3/7, an ancestral caspase from amphioxus (Branchiostoma f...
Isolation of AmphiCASP-3/7, an ancestral caspase from amphioxus (Branchiostoma floridae). Evolutionary considerations for vertebrate caspases.
Cell Death Differ. 2002 Oct ;9(10):1078-89.

PubMed
Ventilatory function in normal Nigerian school children.
Ventilatory function in normal Nigerian school children.
Afr J Med Med Sci. 1979 Mar-Jun ;8(1-2):25-9.

PubMed
Association of a common allelic polymorphism (C677T) in the methylene tetrahydro...
Association of a common allelic polymorphism (C677T) in the methylene tetrahydrofolate reductase gene with a reduced risk of osteoporotic fractures. A case control study in Danish postmenopausal women.
Calcif Tissue Int. 2002 Nov ;71(5):386-92. Epub 2002 Sep 18 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: